HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma

NCT02487849 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped actually limited personnel ressources

Conditions

Epithelial Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer

Interventions

PROCEDURE: HIPEC
DRUG: Carboplatin

Sponsor

Krankenhaus Barmherzige Schwestern Linz